BioNTech CEO confident vaccine will work on UK variant

Coronavirus
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

BERLIN — The chief executive of BioNTech said the German pharmaceutical company is confident that its coronavirus vaccine works against the UK variant, but further studies are needed to be completely sure.

Ugur Sahin said Tuesday that “we don’t know at the moment if our vaccine is also able to provide protection against this new variant,” but because the proteins on the variant are 99% the same as the prevailing strains, BioNTech has “scientific confidence” in the vaccine.

Sahin said BioNTech is currently conducting further studies and hopes to have certainty within the coming weeks.

BioNTech’s vaccine, developed together with U.S. pharmaceutical company Pfizer, is authorized for use in more than 45 countries.

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Connect with PIX11 Online

Connect with PIX11 Online

Trending Stories

Global Coronavirus Tracker

Don't Miss